Skip to main content
. 2020 Jan 31;22(1):11–28. doi: 10.5853/jos.2019.02103

Table 2.

Studies of frequency and/or severity of depression after SAH

Study Study design and setting Timing after SAH Cut off point Proportion of participants with depression (%) Depressive symptom scores (mean±SD) Limitations
Depression measured by rating instruments/questionnaires
Alfieri et al. (2008) [17] Longitudinal study, hospitalized patients On admission (T1) NR NR T1: 17.1±6.5 Small sample size
1 mo (T2) T2: 22.1±3.6
1 yr (T3) T3: 19.9±4.8
3 yr (T4) T4: 14.3±3.8
5 yr (T5) T5: 13.2±3.8
Caeiro et al. (2011) [54] Prospective study, consecutive admissions to an academic neurosurgery center ≤4 day MADRS ≥7 45 9.2±7.3 Sample biased towards SAH of mild severity, depression not assessed at subacute and chronic stage of SAH
Meyer et al. (2010) [44] Longitudinal study At discharge (T1) BDI >10 T1: 24.8 NR Patients with aphasia excluded, possible confounders not measured.
12 mo (T2) T2: 61.7
Passier et al. (2010) [14], Passier et al. (2011) [15], Passier et al. (2012) [16] Cross-sectional study, all subjects treated with clipping or coiling 3 mo BDI ≥10 40 9.6±6.9 Nursing home patients not included.
Powell et al. (2002) [18] and Powell et al. (2004) [19] Cross-sectional study, consecutive admissions to a neurovascular service 3 mo (T1) BDI >10 T1: 9.1 T1: 9.6±6.2 Small sample size
9 mo (T2) T2: 11.4 T2: 9.2±6.9
18 mo (T3) T3: 16.3 T3: 9.4±7.3
Ackermark et al. (2017) [41] Longitudinal study, subjects recruited from a clinic 3 mo (T1) BDI ≥10 T1: 39 T1: 8.9±7.0 Nursing home patients not included, no data of previous mental health problems, locus of control, optimism or social support, self-report of depressive symptoms.
1 yr (T2) T2: 41 T2: 9.3±7.1
2–5 yr (T3) T3: 54 T3: 11.2±8.0
Kronvall et al. (2016) [60] Prospective study in an academic neurosurgery unit 3–6 mo (T1) NR NR T1: 15.0±3.5 Small sample size, validity of the mood assessment uncertain
6–12 mo (T2) T2: 15.3±2.9
12–24 mo (T3) T3: 15.8±2.9
Wong et al. (2012) [57] Prospective multi-center study of consecutive admissions 3 mo NR NR 7 (median) Lack of gold standard measure of depression
Kreiter et al. (2013) [53] Prospective study, consecutive admissions to an academic neurosurgery center 3 mo (T1) CESD ≥16 T1: 38 NR Less severely affected subjects more likely to complete follow-up, subjects treated for SAH a decade ago, confounders not considered.
1 yr (T2) T2: 33
Boerboom et al. (2014) [22] and Boerboom et al. (2016) [23,24] Prospective study, consecutive admissions to an academic neurosurgery center 0.4 yr (T1) CESD ≥16 T2: 26.7 T1: 13.7±1.2 Subjects assessed at different time points following SAH.
3.9 yr (T2) T2: 11.9±1.2
Fontanella et al. (2003) [50] Cross-sectional study, all subjects had treated anterior communicating artery bleeding aneurysm 6 mo NR NR 13.8 (SD NR) Small sample size, limited generalizability to patients with other type of SAH
von Vogelsang et al. (2015) [29] Longitudinal study, hospitalized subjects 6 mo (T1) HADS ≥8 T1: 25.0 T1: 5.0 No data on previous history of depression or use of antidepressants during the follow-up period
1 yr (T2) T2: 27.6 T2: 4.0
2 yr (T3) T3: 29.4 T3: 5.0 (median)
Hellawell et al. (1999) [39] Longitudinal study, subjects recruited from a neurosurgical unit 6 mo (T1) NR T1: 8 NR Small sample size, high attrition rate
1 yr (T2) T2: 9
2 yr (T3) T3: 5
Brand et al. (2015) [65] Case-control study, all subjects had treated SAH 5–9 mo NR NR 1.42±0.29 Small sample size, validity of the mood assessment uncertain, confounders not measured.
Pačić-Turk et al. (2016) [64] Prospective study in an academic neurosurgery unit 11 mo (T1) NR NR T1: 1.93 Modest sample size, validity of the mood assessment uncertain
12–48 mo (T2) T2: 2.65
Scherfler et al. (2016) [28] Longitudinal study, subjects recruited from a neurological intensive care unit 1 yr HADS >10 0 1 (median) Small sample size, selected inclusion of patients without visually detectable structural lesions on MRI
Tölli et al. (2018) [25] Longitudinal study, subjects recruited from a neruointensive care unit 1 yr HADS ≥8 23 NR Single center study, small sample size
Orbo et al. (2008) [45] Longitudinal study, all subjects treated with clipping 1 yr BDI ≥14 5 6 (SD NR) Small sample size
Preiss et al. (2007) [46] Longitudinal study, all subjects treated with coiling or clipping 1 yr NR NR 9.4 Relative small sample size, potential selection bias
Haug et al. (2009) [55] Prospective study, all subjects treated for anterior or middle cerebral artery bleeding aneurysm 1 yr NR NR 5.5 (SD NR) Small sample size, subjects with other locations of aneurysms excluded.
Taufique et al. (2016) [52] Prospective study, consecutive admissions to an academic neurosurgery center 1 yr CESD ≥16 33.3 NR Poor grade patients more likely to be lost to follow-up.
Mukerji et al. (2010) [35] Retrospective subject recruitment, all subjects received an angiogram Median 13 mo (range, 12–266) NR 13 NR Subjects recruited at different time points following SAH, small sample size
Morris et al. (2004) [40] Cross-sectional study, method and site of recruitment not reported Average 16 mo (range, 14–23) BDI ≥10 50 NR Small sample size, opportunity samples, subjects recruited at different time points following SAH
Gill et al. (2015) [31] Cross-sectional study, subjects recruited from neuropsychology services, charities and online support network Average 21.1 mo (range, 2–58) HADS ≥8 51 NR No data on those refused to participate, self-report data of SAH, severity of injury not recorded, subjects, recruited at different time points following SAH.
Fertl et al. (1999) [51] Cross-sectional study, all subjects treated for SAH Average 22 mo (range, NR) ≥12 28 NR Small sample size, subjects recruited at different time points following SAH
Kreitschmann-An-dermahr et al. (2007) [47] Cross-sectional study, method and site of recruitment not reported Average 27.3 mo (range, 12–66) BDI >10 37.5 8.33±5.85 Small sample size, subjects recruited at different time points following SAH
Wong et al. (2014) [3] Cross-sectional four centers study, hospitalized subjects Average NR (range, 1–4 yr) - 13 NR Attrition, subjects recruited at different time points following SAH, confounders not measured, reporting bias
Visser-Meily et al. (2009) [36] Cross-sectional study, all subjects had been treated with coiling or clipping Average 3 yr (range, 2–4) HADS ≥8 23 4.8±3.9 Selection bias as only patients still alive included, subjects recruited at different time points following SAH.
Noble et al. (2014) [32] Cross-sectional study, subjects recruited from support groups Median 3 yr (range, 1–5) HADS ≥8 45.2 NR Only patients had access to internet included, no data on those refused to participate, lack of psychiatric interviews, self-report data of SAH details, subjects recruited at different time points following SAH.
Hütter et al. (1995) [20,21] Cross-sectional study, all subjects operated for SAH Median 3 yr (range, 1–5) BDI >10 30 NR Small sample size, subjects recruited at different time points following SAH, excluded subjects had worse SAH grading.
Carter et al. (2000) [61] Cross-sectional study, consecutive admissions to a tertiary medical center Average NR (range, 1–5 yr) ZDS ≥50 36 45.6 (SD NR) Subjects recruited at different time points following SAH
Latimer et al. (2013) [33] Retrospective subject recruitment, all subjects had anterior circulatory area SAH 40–45 mo NR NR 6.7 Retrospective subject recruitment, selective sample, small sample size
Colledge et al. (2017) [12,13] and Gerber et al. (2016) [42] Cross-sectional study, almost all subjects treated with clipping 44 mo NR NR 8.9±6.6 Small sample size, subjects recruited at different time points following SAH, lack of psychiatric interview
Vetkas et al. (2013) [59] Retrospective study of a single academic center Average 4.5 yr (range, 1–10) GDS ≥12 30 8.4±6.9 Retrospective study, subjects assessed at different time points following SAH
Buunk et al. (2015) [30] Cross-sectional study, all subjects had been treated by coiling or clipping Average 4.6 yr (range, 2–10) HADS ≥8 23 4.2±4.3 Selective sample, subjects recruited at different time points following SAH
Boerboom et al. (2017) [27] Cross-sectional study, hospitalized subjects Average 4.7 yr (range, NR) HADS ≥8 15.2 3.5 (SD NR) Selection bias, small sample size, subjects recruited at different time points following SAH
Salmond et al. (2006) [48] Cross-sectional study, method and site of recruitment not reported Average 68 mo (range, 14–99) NR NR 6.5±1.4 Small sample size, subjects recruited at different time points following SAH
Wermer et al. (2007) [38] Cross-sectional study, all subjects treated with clipping Average 8.9 yr (range, 2.3–18.8) HADS >10 9.4 6.2±3.1 Only patients treated with clipping and regained functional independence included, relative young age of the subjects, subjects recruited at different time points following SAH.
von Vogelsang et al. (2013) [34] Retrospective subject recruitment, subjects recruited from a neurosurgical clinic Average 10.1 yr (range, 8.8–12) HADS ≥8 23.5 4.0 (median) Subjects recruited at different time points following SAH, no data on previous history of depression or use of antidepressants during the followup period
King et al. (2009) [37] Cross-sectional study, subjects recruited from neurosurgery clinics NR HADS >10 9 4.8±3.4 A single academic center study, some eligible patients not participated, Caucasians over-represented
Depression measured by interview
Ljunggren et al. (1985) [63] Cross-sectional study, all subjects had treated SAH and good neurological recovery Average 3.5 yr (range, 14 mo–7 yr) - 25 NR Attrition, sampling bias, subjects recruited at different time points following SAH, self-report of depression
Hedlund et al. (2011) [62] Prospective study, all subjects had treated SAH and good neurological outcome 7 mo - 21 NR Attrition, sampling bias

SAH, subarachnoid hemorrhage; SD, standard deviation; NR, not reported; MADRS, Montgomery Åsberg Depression Rating Scale; BDI, Beck Depression Inventory; CESD, Center for Epidemiologic Studies Depression; HADS, Hospital Anxiety Depression Scale; MRI, magnetic resonance imaging; ZDS, Zung Depression Scale; GDS, Geriatric Depression Scale.